|
CA2522756A1
|
|
Dihydrothiazine prodrugs of thiazolium agents
|
|
US7144570B2
|
|
Sunscreen compositions and methods of use thereof
|
|
US2003176426A1
|
|
Method for treating fibrotic diseases or other indications with imidazolium agents
|
|
US2003027820A1
|
|
Method for treating fibrotic diseases or other indications V
|
|
EP1414464A2
|
|
Method for treating glaucoma v
|
|
WO02096317A2
|
|
Method for treating glaucoma vi
|
|
CA2448294A1
|
|
Method for treating fibrotic diseases or other indications vi
|
|
EP1353669A1
|
|
Method for treating glaucoma
|
|
EP1353674A1
|
|
Method for treating glaucoma ivb
|
|
AU2002232919A1
|
|
Method for treating fibrotic diseases or other indications
|
|
EP1359918A1
|
|
Method for treating glaucoma iiib
|
|
CA2433425A1
|
|
Method for treating fibrotic diseases or other indications iiic
|
|
EP1359910A1
|
|
Method for treating glaucoma ii b
|
|
WO02053161A1
|
|
Method for treating fibrotic diseases or other indications
|
|
CA2415054A1
|
|
Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
|
|
WO0193854A1
|
|
Method for treating hyperglycemia
|
|
AU4968301A
|
|
Synthesis of thiazolium compounds
|
|
NZ520573A
|
|
Thiazolium compounds and treatments of disorders associated with protein aging
|
|
EP1248615A1
|
|
Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
|
|
US6326396B1
|
|
Glucose and lipid lowering compounds
|
